Ebert D H, Bischof L J, Streeper R S, Chapman S C, Svitek C A, Goldman J K, Mathews C E, Leiter E H, Hutton J C, O'Brien R M
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232-0615, USA.
Diabetes. 1999 Mar;48(3):543-51. doi: 10.2337/diabetes.48.3.543.
In liver and kidney, the terminal step in the gluconeogenic pathway is catalyzed by glucose-6-phosphatase (G-6-Pase). This enzyme is actually a multicomponent system, the catalytic subunit of which was recently cloned. Numerous reports have also described the presence of G-6-Pase activity in islets, although the role of G-6-Pase in this tissue is unclear. Arden and associates have described the cloning of a novel cDNA that encodes an islet-specific G-6-Pase catalytic subunit-related protein (IGRP) (Arden SD, Zahn T, Steegers S, Webb S, Bergman B, O'Brien RM, Hutton JC: Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP). Diabetes 48:531-542, 1999). We screened a mouse BAC library with this cDNA to isolate the IGRP gene, which spans approximately 8 kbp of genomic DNA. The exon/intron structure of the IGRP gene has been mapped and, as with the gene encoding the liver/kidney G-6-Pase catalytic subunit, it is composed of five exons. The sizes of these exons are 254 (I), 110 (II), 112 (III), 116 (IV), and 1284 (V) bp, similar to those of the G-6-Pase catalytic subunit gene. Two interspecific backcross DNA mapping panels were used to unambiguously localize the IGRP gene (map symbol G6pc-rs) to the proximal portion of mouse chromosome 2. The IGRP gene transcription start site was mapped by primer extension analysis, and the activity of the IGRP gene promoter was analyzed in both the islet-derived HIT cell line and the liver-derived HepG2 cell line. The IGRP and G-6-Pase catalytic subunit gene promoters show a reciprocal pattern of activity, with the IGRP promoter being approximately 150-fold more active than the G-6-Pase promoter in HIT cells.
在肝脏和肾脏中,糖异生途径的最后一步由葡萄糖-6-磷酸酶(G-6-Pase)催化。该酶实际上是一个多组分系统,其催化亚基最近已被克隆。许多报告也描述了胰岛中存在G-6-Pase活性,尽管G-6-Pase在该组织中的作用尚不清楚。阿登及其同事描述了一种新型cDNA的克隆,该cDNA编码一种胰岛特异性G-6-Pase催化亚基相关蛋白(IGRP)(阿登SD、扎恩T、斯特格斯S、韦伯S、伯格曼B、奥布赖恩RM、赫顿JC:胰腺胰岛特异性葡萄糖-6-磷酸酶催化亚基相关蛋白(IGRP)的分子克隆。《糖尿病》48:531 - 542,1999年)。我们用该cDNA筛选了一个小鼠BAC文库,以分离IGRP基因,该基因跨越约8千碱基对的基因组DNA已绘制出IGRP基因的外显子/内含子结构,与编码肝脏/肾脏G-6-Pase催化亚基的基因一样,它由五个外显子组成。这些外显子的大小分别为254(I)、110(II)、112(III)、116(IV)和1284(V)碱基对,与G-6-Pase催化亚基基因的外显子大小相似。使用两个种间回交DNA定位板将IGRP基因(图谱符号G6pc-rs)明确地定位到小鼠2号染色体的近端部分。通过引物延伸分析确定了IGRP基因转录起始位点,并在胰岛来源的HIT细胞系和肝脏来源的HepG2细胞系中分析了IGRP基因启动子的活性。IGRP和G-6-Pase催化亚基基因启动子表现出相反的活性模式,在HIT细胞中,IGRP启动子的活性比G-6-Pase启动子高约150倍。